Clinical Trials in Nashville

Showing 17161-17180 of 20,298 trials

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

NCT01993225

This is a Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men with Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment with 12.5 mg or 25 mg Androxal or AndroGel 1.62%.

Secondary Hypogonadism

Repros Therapeutics Inc.120 participantsStarted Jan 2014

Birmingham, Alabama, United States • Mobile, Alabama, United States • Evanston, Illinois, United States +6 more locations

COMPLETEDPhase 1< 1 mile

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

NCT00888069

This study will investigate how the levels of a single dose of CTAP101 changes in the body over time (pharmacokinetics, PK) and how CTAP101 affects other mineral and hormonal balances (pharmacodynamics, PD) in patients with Stage 3 or 4 chronic kidney disease (CKD) with vitamin D insufficiency and secondary hyperparathyroidism (SHPT).

Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more

OPKO IP Holdings II, Inc.28 participantsStarted May 2009

Peoria, Arizona, United States • Evergreen Park, Illinois, United States • Springfield, Massachusetts, United States +9 more locations

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Find Trials by Condition in Nashville

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

Adenovirus Vaccine for Malaria

A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

The OMEGA Clinical Trial

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Social and Communication Outcomes for Young Children With Autism

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools

Impact of Pulse-enriched Foods on Cognitive Function and Cardiometabolic Health in Obese Adults